This study evaluates the feasibility, safety, and short-term outcomes of intravenous sotalol initiation using abbreviated inpatient telemetry and extended ambulatory monitoring.
This study evaluates the feasibility, safety, and short-term outcomes of intravenous sotalol initiation using abbreviated inpatient telemetry and extended ambulatory monitoring.
This article offers an inside look at Intermountain Health’s EP program, showcasing a legacy of innovation, collaborative culture, and advanced therapies that drive high-quality, research-engaged heart rhythm care.
This article offers an inside look at Intermountain Health’s EP program, showcasing a legacy of innovation, collaborative culture, and advanced therapies that drive high-quality, research-engaged heart rhythm care.
Sandeep Goyal, MD, discusses how Piedmont Healthcare has integrated 2 key technologies shaping the future of AF treatment: the Affera™ mapping and ablation system and PulseSelect™ PFA system (Medtronic).
Sandeep Goyal, MD, discusses how Piedmont Healthcare has integrated 2 key technologies shaping the future of AF treatment: the Affera™ mapping and ablation system and PulseSelect™ PFA system (Medtronic).
Visual auras after AF ablation—migraine or warning sign? New trial data show up to 15% of patients experience visual auras after left-sided ablation, highlighting the need to reduce cerebral embolic risk and recognize “silent” emboli.
Visual auras after AF ablation—migraine or warning sign? New trial data show up to 15% of patients experience visual auras after left-sided ablation, highlighting the need to reduce cerebral embolic risk and recognize “silent” emboli.
